THIRD LICENSE AGREEMENT BETWEEN LEXEO THERAPEUTICS, INC. AND CORNELL UNIVERSITY FOR DOCKET NO. D-9332, D-10224, D-11139 CTL CONTRACT NO. [***]Third License Agreement • August 12th, 2024 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Third License Agreement (this “Agreement”) is made by and between Lexeo Therapeutics, Inc., a Delaware corporation, having an office at 345 Park Avenue South, 6th Floor, New York, NY 10010 (“LICENSEE”), and Cornell University, a New York education corporation (“Cornell”), as represented by its Cornell Center for Technology Licensing (“CTL”) at 395 Pine Tree Road, Suite 310, Ithaca, NY 14850. Cornell and LICENSEE each may be referred to herein as a “Party” and together as the “Parties.”
